Ureteral ObstructionNCT02419339
Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction
An observational study of Ureteral Obstruction and Urinary Diversion, run by University of Nebraska at 1 site in United States.
Trial summary
Prospective multicenter observational study of early infancy ureteral reimplantation for distal ureteral obstruction. The study is an observation study since the investigators will not assign specific interventions to the subjects of the study. Read more about this study
- Who is it for?
- Ages Up to 6 months
- Conditions the study is for
- Ureteral Obstruction, Urinary Diversion
- What is being tested?
- Extravesical ureteral reimplantation
- Type of treatment
- Surgery or procedure
- How many people
- 5 participants
- Where
- 1 siteUnited States
- Study dates
- 22 May 2015to 4 Jun 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 6 months
- All sexes
- No healthy volunteers
- Child
Study population: Infants (under 6 months of age) undergoing an extravesical ureteral reimplant for primary obstructed megaureter or ectopic ureter.
Who may be able to join
- Children younger 6 months of age who have been recommended by their urologist to have a unilateral ureteral reimplant.
- Unilateral obstructive disease (as defined by the BAPU)
- Ipsilateral Single system
- Ipsilateral VUR is ok
- Contralateral reflux grades 1-3 ok as long as the reflux will be observed
Who cannot join
- Duplicated systems
- First Febrile UTI's and megaureter or ectopic ureter but no evidence of obstruction or loss of function
- Neurogenic bladder, valves
- Contralateral reflux grade 4-5
Trial locations and contacts
1 site in 1 country.
United States1 site
Children's Hospital and Medical Center
Omaha, Nebraska, 68114
About this study
Official title: Prospective Multicenter Observational Study of Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction
Prospective multicenter observational study of early infancy ureteral reimplantation for distal ureteral obstruction.
The study is an observation study since the investigators will not assign specific interventions to the subjects of the study.
The purpose of the study is to describe the surgical outcomes of early infancy ureteral reimplantation. Infants under 6 months of age with unilateral obstructed distal ureter, no other urologic pathologic and a normal contralateral kidney who have been recommended a ureteral reimplant by their pediatric urologist are eligible for the study. Patients that consent for the study will be prospectively followed for 1 year to record the outcomes of the surgery.
Read the detailed description
Initial evaluation and determining if surgery is indicated:
Prenatal diagnosis: patient will get renal ultrasound at 2-7 days of birth and will be started on prophylaxis with amoxicillin or Keflex. At 6 weeks a VCUG, renal ultrasound and mag 3 will be done per local protocols.
Patients considered for reimplant will have:
- SFU grade 3 and 4 hydroureteronephrosis
- Normal contralateral kidney (VUR grade 1-3 ok) as defined above plus
- Obstruction As defined by the BAPU (British Association of Paediatric Urologists consensus statement on the management of the primary obstructive megaureter)
If the patient meets criteria they will be consented for this observational study (before the surgery) and will have an extravesical ureteral reimplant in the next 0-2 months.
After the patient has been consented to participate in the study and before surgery, the investigators need to notify the main study site (Omaha) about the new patient and information will be recorded at the main site about the patient without patient identifiers. This is done so that they study can be analyze as an intention to treat.
Please note that this is an observational study: patients will have the same interventions and diagnostic tests regardless whether they chose or not to participate in the study. The investigator does not assign specific interventions to the subjects of the study. The protocol is only a suggested guideline to standardize details of the surgery and follow up of the patients among the different centers.
Postnatal diagnosis: patients with no history of prenatal hydronephrosis presenting with febrile UTI. If under 6 weeks of age they will be placed on prophylaxis with amoxicillin or Keflex. At 6 weeks a VCUG, renal ULTRASOUND and mag 3 will be done per local protocols. If presenting in between 6 weeks and 6 months of life they will undergo VCUG and Mag 3 after completing antibiotics course (7-10 days). Patients with febrile UTI not responding to antibiotics can be diverted with a percutaneous nephrostomy and once stable undergo testing.
Patients considered for reimplant will have:
- SFU grade 3 and 4 hydroureteronephrosis
- Normal contralateral kidney as defined above plus
- Obstruction As defined by the BAPU If the patient fulfills criteria and the reimplant can be scheduled before age 7 months, they will be consented for the study.
After the patient has been consented to participate in the study and before surgery, the investigators need to notify the main study site (Omaha) about the new patient and information will be recorded at the main site about the patient without patient identifiers. This is done so that they study can be analyze as an intention to treat.
Patients initially not meeting criteria for surgery who had breakthrough UTI's Patients with unilateral megaureter but either no obstruction as defined above or no differential function loss can be considered for the study if they have Breakthrough UTI's while on prophylaxis and the surgery will be done at less than 7 months of age.
Follow up If patient does not meet criteria for surgery, follow up will be done as per local protocols with renal US +/- Mag 3 renal scans.
Follow up US can be done every 6-12 weeks. If US shows worsening patient can proceed with surgery or a Mag 3 can be done alternatively and any worsening >5% DFx on the mag 3 can could indicate surgery.
Below is a summary of patients eligible for surgery (all surgeries will have to be done under 7 months of age to enter into the study as well as inclusion and exclusion criteria must be followed):
- Prenatally diagnosed unilateral distal obstruction that at 6 weeks have less than 40% DFx and SFU 3 or 4 hydronephrosis.
- Patients who present postnatally with a febrile UTI and unilateral distal ureteral obstruction and on evaluation are found to have less than 40% DFx, and SFU 3 or 4 hydronephrosis.
- Prenatally or postnatally diagnosed patients with distal obstruction who on initial evaluation did not meet criteria, but then subsequently had a Breakthrough febrile UTI's while on abx prophylaxis.
- Prenatally or postnatally diagnosed patients with distal obstruction who on initial evaluation did not meet criteria, but on follow up US showed worsening hydronephrosis. Alternatively for these patients a Mag 3 can be repeated with surgery done for worsening parameters on the mag 3 (loss of more than 5% of function) .
Operative considerations Pfannenstiel incision. Fascial incision can be vertical or horizontal. Ureter dissected and divided at the bladder with 4-0 polydioxanone (suture ligation) if megaureter or as distal as possible/safe for ectopic ureter. Distal narrow or diseased looking segment excised.
Using 4 4-0 silk stay sutures, the borders or the detrusorrhaphy will be marked posterior laterally. A 3 cm detrusorrhaphy (minimum) down to mucosa will be done next.
Tapering (optional). Ureters more than 8-10 mm in diameter could be tapered. Based on some computer models research done by us, would recommend tapering just the distal ureter down to 4-5 mm in diameter over a stent left for 6 weeks. Ureter should not be tapered for more than a few centimeters in length to avoid devascularization. Alternatively, tapering can be left to the discretion of the surgeon.
The ureter will be anastomosed with running 5-0 or 6-0 polyglactin to the distal detrusorrhaphy making only a small mucosal opening.
A distal advancement suture will be placed to secure the UO distally in the bladder.
The detrusor will be then closed with interrupted 3-0 polyglactin stitches making sure no to obstruct the ureter proximal at the hiatus.
For non tapered reimplants, a stent will be sutured to the foley and removed in 5-7 days.
Drain at the discretion of the surgeon (preferably no drain) Foley will be left for 5-7 days in everyone. Overnight observation for all patients with extended hospital stay as needed for complications.
Follow up Antibiotic prophylaxis until first VCUG. (sulfamethoxazole/trimethoprim 3-4 mg/kg/day) 3 months: renal US, and VCUG. Mag 3 only for cases where the renal US showed no improvement (renal US stable or worse). Mag 3 can be done per the discretion of the surgeon too.
Continue antibiotic prophylaxis for girls and uncircumcised boys with VUR. May stop antibiotic prophylaxis for circumcised boy with VUR.
1 year: renal US, and VCUG (if previous VCUG showed VUR). Mag 3 only for cases where the renal US showed no improvement (renal US stable or worse). Mag 3 can be done per the discretion of the surgeon too.
Recurrent Febrile UTI's: will document any febrile UTI's defined at temp more than 38.5 with urine analysis with >10 white blood cells per high power field on microscopic exam and a positive urine culture more than 1 months after removal of foley or stent. Febrile UTI's within a month of the removal of foley or stent will be considered operative complications.
- Conditions
- Ureteral Obstruction, Urinary Diversion
- Being tested
- Extravesical ureteral reimplantation
- Medical subject headings
- Ureteral Obstruction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Extravesical ureteral reimplantationProcedure or surgery
Extravesical ureteral reimplantation with or without tapering
What is being measured
The primary outcome is the main question the study is designed to answer.
Reoperation
Need for reoperation either for persistent documented obstruction or reflux with recurrent febrile UTI's
Measured: 1 year
Secondary outcomes (1)
Recurrent Febrile UTI's
Recurrent febrile urinary tract infections defined as fever more than 38.5, positive urine culture with more than 100,000 organism from a cath specimen and urine analysis with more than 10 leukocytes per high power field.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2015 (estimated)
- Study start22 May 2015
- Primary completion4 Jun 2019
- Study completion4 Jun 2019
Why it stopped: Principal investigator is moving to a different institution.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (13)Papers the sponsor has linked to this study.
- Other trials for Ureteral ObstructionStudies of the same condition, open and under way.
- More trials run by University of NebraskaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 5 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Nebraska
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Carlos A Villanueva, MD, Principal investigator, University of Nebraska
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02419339
- Sponsor's protocol ID
- 0368-15-EP
- Status last verified
- Oct 2023
- First submitted
- 8 Apr 2015
- Last updated
- 6 Oct 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
de Jong TP, Dik P, Klijn AJ, Uiterwaal CS, van Gool JD. Ectopic ureterocele: results of open surgical therapy in 40 patients. J Urol. 2000 Dec;164(6):2040-3; discussion 2043-4.
PubMed 11061921de Kort LM, Klijn AJ, Uiterwaal CS, de Jong TP. Ureteral reimplantation in infants and children: effect on bladder function. J Urol. 2002 Jan;167(1):285-7. doi: 10.1097/00005392-200201000-00084.
PubMed 11743341Gearhart JP. Primary obstructive ureter in neonates. Treatment by temporary uretero-cutaneostomy. Br J Urol. 1994 Jul;74(1):133-4. No abstract available.
PubMed 8044519Greenfield SP, Griswold JJ, Wan J. Ureteral reimplantation in infants. J Urol. 1993 Nov;150(5 Pt 1):1460-2. doi: 10.1016/s0022-5347(17)35809-3.
PubMed 8411425Kaefer M, Misseri R, Frank E, Rhee A, Lee SD. Refluxing ureteral reimplantation: a logical method for managing neonatal UVJ obstruction. J Pediatr Urol. 2014 Oct;10(5):824-30. doi: 10.1016/j.jpurol.2014.01.027. Epub 2014 Feb 28.
PubMed 24850437Kitchens DM, DeFoor W, Minevich E, Reddy P, Polsky E, McGregor A, Sheldon C. End cutaneous ureterostomy for the management of severe hydronephrosis. J Urol. 2007 Apr;177(4):1501-4. doi: 10.1016/j.juro.2006.11.076.
PubMed 17382764Kogan BA, Gohary MA. Cutaneous ureterostomy as a permanent external urinary diversion in children. J Urol. 1984 Oct;132(4):729-31. doi: 10.1016/s0022-5347(17)49844-2.
PubMed 6471219Lee SD, Akbal C, Kaefer M. Refluxing ureteral reimplant as temporary treatment of obstructive megaureter in neonate and infant. J Urol. 2005 Apr;173(4):1357-60; discussion 1360. doi: 10.1097/01.ju.0000152317.72166.df.
PubMed 15758801Liu C, Chin T, Wei C. Surgical treatment of vesicoureteral reflux in infants under 3 months of age. J Pediatr Surg. 1998 Nov;33(11):1716-9. doi: 10.1016/s0022-3468(98)90617-0.
PubMed 9856903MacGregor PS, Kay R, Straffon RA. Cutaneous ureterostomy in children--long-term followup. J Urol. 1985 Sep;134(3):518-20. doi: 10.1016/s0022-5347(17)47271-5.
PubMed 4032552Peters CA, Mandell J, Lebowitz RL, Colodny AH, Bauer SB, Hendren WH, Retik AB. Congenital obstructed megaureters in early infancy: diagnosis and treatment. J Urol. 1989 Aug;142(2 Pt 2):641-5; discussion 667-8. doi: 10.1016/s0022-5347(17)38842-0.
PubMed 2746792Sarduy GS, Crooks KK, Smith JP, Wise HA 2nd. Results in children managed by cutaneous ureterostomy. Urology. 1982 May;19(5):486-8. doi: 10.1016/0090-4295(82)90604-5.
PubMed 7080321Farrugia MK, Hitchcock R, Radford A, Burki T, Robb A, Murphy F; British Association of Paediatric Urologists. British Association of Paediatric Urologists consensus statement on the management of the primary obstructive megaureter. J Pediatr Urol. 2014 Feb;10(1):26-33. doi: 10.1016/j.jpurol.2013.09.018. Epub 2013 Oct 16.
PubMed 24206785
Study at a glance
From the registry record, last updated by the sponsor on 6 Oct 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prospective Multicenter Observational Study of Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction
- ClinicalTrials.gov ID
- NCT02419339
- Acronym / sponsor ID
- 0368-15-EP
- Conditions
- Ureteral Obstruction, Urinary Diversion
- Study type
- Observational
- Recruitment status
- TerminatedReason stopped: Principal investigator is moving to a different institution.
- Enrolment
- 5 participants (actual)
- Lead sponsor
- University of NebraskaUniversity, hospital or other
- Study start
- 22 May 2015 (actual)
- Primary completion
- 4 Jun 2019 (actual)
- Study completion
- 4 Jun 2019 (actual)
- First posted
- 17 Apr 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prospective multicenter observational study of early infancy ureteral reimplantation for distal ureteral obstruction.
The study is an observation study since the investigators will not assign specific interventions to the subjects of the study.
The purpose of the study is to describe the surgical outcomes of early infancy ureteral reimplantation. Infants under 6 months of age with unilateral obstructed distal ureter, no other urologic pathologic and a normal contralateral kidney who have been recommended a ureteral reimplant by their pediatric urologist are eligible for the study. Patients that consent for the study will be prospectively followed for 1 year to record the outcomes of the surgery.
Detailed description
Initial evaluation and determining if surgery is indicated:
Prenatal diagnosis: patient will get renal ultrasound at 2-7 days of birth and will be started on prophylaxis with amoxicillin or Keflex. At 6 weeks a VCUG, renal ultrasound and mag 3 will be done per local protocols.
Patients considered for reimplant will have:
- SFU grade 3 and 4 hydroureteronephrosis
- Normal contralateral kidney (VUR grade 1-3 ok) as defined above plus
- Obstruction As defined by the BAPU (British Association of Paediatric Urologists consensus statement on the management of the primary obstructive megaureter)
If the patient meets criteria they will be consented for this observational study (before the surgery) and will have an extravesical ureteral reimplant in the next 0-2 months.
After the patient has been consented to participate in the study and before surgery, the investigators need to notify the main study site (Omaha) about the new patient and information will be recorded at the main site about the patient without patient identifiers. This is done so that they study can be analyze as an intention to treat.
Please note that this is an observational study: patients will have the same interventions and diagnostic tests regardless whether they chose or not to participate in the study. The investigator does not assign specific interventions to the subjects of the study. The protocol is only a suggested guideline to standardize details of the surgery and follow up of the patients among the different centers.
Postnatal diagnosis: patients with no history of prenatal hydronephrosis presenting with febrile UTI. If under 6 weeks of age they will be placed on prophylaxis with amoxicillin or Keflex. At 6 weeks a VCUG, renal ULTRASOUND and mag 3 will be done per local protocols. If presenting in between 6 weeks and 6 months of life they will undergo VCUG and Mag 3 after completing antibiotics course (7-10 days). Patients with febrile UTI not responding to antibiotics can be diverted with a percutaneous nephrostomy and once stable undergo testing.
Patients considered for reimplant will have:
- SFU grade 3 and 4 hydroureteronephrosis
- Normal contralateral kidney as defined above plus
- Obstruction As defined by the BAPU If the patient fulfills criteria and the reimplant can be scheduled before age 7 months, they will be consented for the study.
After the patient has been consented to participate in the study and before surgery, the investigators need to notify the main study site (Omaha) about the new patient and information will be recorded at the main site about the patient without patient identifiers. This is done so that they study can be analyze as an intention to treat.
Patients initially not meeting criteria for surgery who had breakthrough UTI's Patients with unilateral megaureter but either no obstruction as defined above or no differential function loss can be considered for the study if they have Breakthrough UTI's while on prophylaxis and the surgery will be done at less than 7 months of age.
Follow up If patient does not meet criteria for surgery, follow up will be done as per local protocols with renal US +/- Mag 3 renal scans.
Follow up US can be done every 6-12 weeks. If US shows worsening patient can proceed with surgery or a Mag 3 can be done alternatively and any worsening >5% DFx on the mag 3 can could indicate surgery.
Below is a summary of patients eligible for surgery (all surgeries will have to be done under 7 months of age to enter into the study as well as inclusion and exclusion criteria must be followed):
- Prenatally diagnosed unilateral distal obstruction that at 6 weeks have less than 40% DFx and SFU 3 or 4 hydronephrosis.
- Patients who present postnatally with a febrile UTI and unilateral distal ureteral obstruction and on evaluation are found to have less than 40% DFx, and SFU 3 or 4 hydronephrosis.
- Prenatally or postnatally diagnosed patients with distal obstruction who on initial evaluation did not meet criteria, but then subsequently had a Breakthrough febrile UTI's while on abx prophylaxis.
- Prenatally or postnatally diagnosed patients with distal obstruction who on initial evaluation did not meet criteria, but on follow up US showed worsening hydronephrosis. Alternatively for these patients a Mag 3 can be repeated with surgery done for worsening parameters on the mag 3 (loss of more than 5% of function) .
Operative considerations Pfannenstiel incision. Fascial incision can be vertical or horizontal. Ureter dissected and divided at the bladder with 4-0 polydioxanone (suture ligation) if megaureter or as distal as possible/safe for ectopic ureter. Distal narrow or diseased looking segment excised.
Using 4 4-0 silk stay sutures, the borders or the detrusorrhaphy will be marked posterior laterally. A 3 cm detrusorrhaphy (minimum) down to mucosa will be done next.
Tapering (optional). Ureters more than 8-10 mm in diameter could be tapered. Based on some computer models research done by us, would recommend tapering just the distal ureter down to 4-5 mm in diameter over a stent left for 6 weeks. Ureter should not be tapered for more than a few centimeters in length to avoid devascularization. Alternatively, tapering can be left to the discretion of the surgeon.
The ureter will be anastomosed with running 5-0 or 6-0 polyglactin to the distal detrusorrhaphy making only a small mucosal opening.
A distal advancement suture will be placed to secure the UO distally in the bladder.
The detrusor will be then closed with interrupted 3-0 polyglactin stitches making sure no to obstruct the ureter proximal at the hiatus.
For non tapered reimplants, a stent will be sutured to the foley and removed in 5-7 days.
Drain at the discretion of the surgeon (preferably no drain) Foley will be left for 5-7 days in everyone. Overnight observation for all patients with extended hospital stay as needed for complications.
Follow up Antibiotic prophylaxis until first VCUG. (sulfamethoxazole/trimethoprim 3-4 mg/kg/day) 3 months: renal US, and VCUG. Mag 3 only for cases where the renal US showed no improvement (renal US stable or worse). Mag 3 can be done per the discretion of the surgeon too.
Continue antibiotic prophylaxis for girls and uncircumcised boys with VUR. May stop antibiotic prophylaxis for circumcised boy with VUR.
1 year: renal US, and VCUG (if previous VCUG showed VUR). Mag 3 only for cases where the renal US showed no improvement (renal US stable or worse). Mag 3 can be done per the discretion of the surgeon too.
Recurrent Febrile UTI's: will document any febrile UTI's defined at temp more than 38.5 with urine analysis with >10 white blood cells per high power field on microscopic exam and a positive urine culture more than 1 months after removal of foley or stent. Febrile UTI's within a month of the removal of foley or stent will be considered operative complications.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- Up to 6 months
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Infants (under 6 months of age) undergoing an extravesical ureteral reimplant for primary obstructed megaureter or ectopic ureter.
Key inclusion criteria (5 listed)
- Children younger 6 months of age who have been recommended by their urologist to have a unilateral ureteral reimplant.
- Unilateral obstructive disease (as defined by the BAPU)
- Ipsilateral Single system
- Ipsilateral VUR is ok
- Contralateral reflux grades 1-3 ok as long as the reflux will be observed
Key exclusion criteria (4 listed)
- Duplicated systems
- First Febrile UTI's and megaureter or ectopic ureter but no evidence of obstruction or loss of function
- Neurogenic bladder, valves
- Contralateral reflux grade 4-5
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Extravesical ureteral reimplantationExtravesical ureteral reimplantation with or without tapering | Procedure or surgery | – |
Primary outcome
Reoperation
Time frame: 1 year
Need for reoperation either for persistent documented obstruction or reflux with recurrent febrile UTI's
1 secondary outcome
Recurrent Febrile UTI's
Time frame: 1 year
Results and safety
The study was stopped early (reason given: Principal investigator is moving to a different institution.). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Oct 2023.
- Background: PubMed 11061921de Jong TP, Dik P, Klijn AJ, Uiterwaal CS, van Gool JD. Ectopic ureterocele: results of open surgical therapy in 40 patients. J Urol. 2000 Dec;164(6):2040-3; discussion 2043-4.
- Background: PubMed 11743341de Kort LM, Klijn AJ, Uiterwaal CS, de Jong TP. Ureteral reimplantation in infants and children: effect on bladder function. J Urol. 2002 Jan;167(1):285-7. doi: 10.1097/00005392-200201000-00084.
- Background: PubMed 8044519Gearhart JP. Primary obstructive ureter in neonates. Treatment by temporary uretero-cutaneostomy. Br J Urol. 1994 Jul;74(1):133-4. No abstract available.
- Background: PubMed 8411425Greenfield SP, Griswold JJ, Wan J. Ureteral reimplantation in infants. J Urol. 1993 Nov;150(5 Pt 1):1460-2. doi: 10.1016/s0022-5347(17)35809-3.
- Background: PubMed 24850437Kaefer M, Misseri R, Frank E, Rhee A, Lee SD. Refluxing ureteral reimplantation: a logical method for managing neonatal UVJ obstruction. J Pediatr Urol. 2014 Oct;10(5):824-30. doi: 10.1016/j.jpurol.2014.01.027. Epub 2014 Feb 28.
- Background: PubMed 17382764Kitchens DM, DeFoor W, Minevich E, Reddy P, Polsky E, McGregor A, Sheldon C. End cutaneous ureterostomy for the management of severe hydronephrosis. J Urol. 2007 Apr;177(4):1501-4. doi: 10.1016/j.juro.2006.11.076.
- Background: PubMed 6471219Kogan BA, Gohary MA. Cutaneous ureterostomy as a permanent external urinary diversion in children. J Urol. 1984 Oct;132(4):729-31. doi: 10.1016/s0022-5347(17)49844-2.
- Background: PubMed 15758801Lee SD, Akbal C, Kaefer M. Refluxing ureteral reimplant as temporary treatment of obstructive megaureter in neonate and infant. J Urol. 2005 Apr;173(4):1357-60; discussion 1360. doi: 10.1097/01.ju.0000152317.72166.df.
- Background: PubMed 9856903Liu C, Chin T, Wei C. Surgical treatment of vesicoureteral reflux in infants under 3 months of age. J Pediatr Surg. 1998 Nov;33(11):1716-9. doi: 10.1016/s0022-3468(98)90617-0.
- Background: PubMed 4032552MacGregor PS, Kay R, Straffon RA. Cutaneous ureterostomy in children--long-term followup. J Urol. 1985 Sep;134(3):518-20. doi: 10.1016/s0022-5347(17)47271-5.
- Background: PubMed 2746792Peters CA, Mandell J, Lebowitz RL, Colodny AH, Bauer SB, Hendren WH, Retik AB. Congenital obstructed megaureters in early infancy: diagnosis and treatment. J Urol. 1989 Aug;142(2 Pt 2):641-5; discussion 667-8. doi: 10.1016/s0022-5347(17)38842-0.
- Background: PubMed 7080321Sarduy GS, Crooks KK, Smith JP, Wise HA 2nd. Results in children managed by cutaneous ureterostomy. Urology. 1982 May;19(5):486-8. doi: 10.1016/0090-4295(82)90604-5.
Related trials for Ureteral Obstruction
Not yet recruiting
Safety and Efficacy of Ultrasound-Guided Percutaneous Nephrostomy in Oncology Patients
Obstructive Uropathy, Hydronephrosis
Not yet recruitingObservational study
An Integrated Multi-omics Study on the Molecular Mechanisms of Ureteral Stricture
Ureteral Stricture, Ureteral Obstruction
Active, not recruitingObservational study
Radiomics and Image Segmentation of Urinary Stones by Artificial Intelligence
Urinary Stone, Renal Colic
Recruiting
Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction
Hydronephrosis; Obstruction, Ureter, Renal Failure
Recruiting
Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture
Ureteral Stenosis, Hydronephrosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carlos A Villanueva, MD principal investigator
University of Nebraska
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Ureteral Obstruction and Urinary Diversion, run by University of Nebraska at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 6 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Principal investigator is moving to a different institution.). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reoperation (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02419339, which also lists 13 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2023.